Biguanides

Caroline Day*, Clifford J. Bailey

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

Abstract

The biguanides are derivatives of the compound biguanide (guanylguanidine) that exert a blood glucose-lowering effect in type 2 (non-insulin dependent) diabetes mellitus. The main biguanides are metformin (dimethylbiguanide) and phenformin (phenethylbiguanide), which were described in 1957 and buformin (butylbiguaninde), which was described in 1958 ....

Original languageEnglish
Title of host publicationxPharm
Subtitle of host publicationthe comprehensive pharmacology reference
EditorsS.J. Enna, David B. Bylund
PublisherElsevier
Number of pages3
ISBN (Print)978-0-08-055232-3
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Biguanides
Buformin
Phenformin
Metformin
Type 2 Diabetes Mellitus
Blood Glucose

Cite this

Day, C., & Bailey, C. J. (2011). Biguanides. In S. J. Enna, & D. B. Bylund (Eds.), xPharm: the comprehensive pharmacology reference Elsevier. https://doi.org/10.1016/B978-008055232-3.61041-4
Day, Caroline ; Bailey, Clifford J. / Biguanides. xPharm: the comprehensive pharmacology reference. editor / S.J. Enna ; David B. Bylund. Elsevier, 2011.
@inbook{6e33844742164f2b82b1a7ecdc28e8fe,
title = "Biguanides",
abstract = "The biguanides are derivatives of the compound biguanide (guanylguanidine) that exert a blood glucose-lowering effect in type 2 (non-insulin dependent) diabetes mellitus. The main biguanides are metformin (dimethylbiguanide) and phenformin (phenethylbiguanide), which were described in 1957 and buformin (butylbiguaninde), which was described in 1958 ....",
author = "Caroline Day and Bailey, {Clifford J.}",
year = "2011",
month = "2",
doi = "10.1016/B978-008055232-3.61041-4",
language = "English",
isbn = "978-0-08-055232-3",
editor = "S.J. Enna and Bylund, {David B.}",
booktitle = "xPharm",
publisher = "Elsevier",
address = "Netherlands",

}

Day, C & Bailey, CJ 2011, Biguanides. in SJ Enna & DB Bylund (eds), xPharm: the comprehensive pharmacology reference. Elsevier. https://doi.org/10.1016/B978-008055232-3.61041-4

Biguanides. / Day, Caroline; Bailey, Clifford J.

xPharm: the comprehensive pharmacology reference. ed. / S.J. Enna; David B. Bylund. Elsevier, 2011.

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

TY - CHAP

T1 - Biguanides

AU - Day, Caroline

AU - Bailey, Clifford J.

PY - 2011/2

Y1 - 2011/2

N2 - The biguanides are derivatives of the compound biguanide (guanylguanidine) that exert a blood glucose-lowering effect in type 2 (non-insulin dependent) diabetes mellitus. The main biguanides are metformin (dimethylbiguanide) and phenformin (phenethylbiguanide), which were described in 1957 and buformin (butylbiguaninde), which was described in 1958 ....

AB - The biguanides are derivatives of the compound biguanide (guanylguanidine) that exert a blood glucose-lowering effect in type 2 (non-insulin dependent) diabetes mellitus. The main biguanides are metformin (dimethylbiguanide) and phenformin (phenethylbiguanide), which were described in 1957 and buformin (butylbiguaninde), which was described in 1958 ....

UR - http://www.scopus.com/inward/record.url?scp=84883923426&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.61041-4

DO - 10.1016/B978-008055232-3.61041-4

M3 - Chapter (peer-reviewed)

AN - SCOPUS:84883923426

SN - 978-0-08-055232-3

BT - xPharm

A2 - Enna, S.J.

A2 - Bylund, David B.

PB - Elsevier

ER -

Day C, Bailey CJ. Biguanides. In Enna SJ, Bylund DB, editors, xPharm: the comprehensive pharmacology reference. Elsevier. 2011 https://doi.org/10.1016/B978-008055232-3.61041-4